State of Wyoming’s Coherus Oncology CHRS Stock Holding History

State of Wyoming’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-49,099	Closed	-$39.6K	–	1894
2025 Q1	$39.6K	Sell	49,099 -70,171	-59%	-$80.8K	0.01%	1525
2024 Q4	$165K	Buy	119,270 +45,405	+61%	+$50.9K	0.02%	952
2024 Q3	$76.8K	Buy	+73,865	New	+$101K	0.01%	1276
2022 Q1	–	Sell	-2,890	Closed	-$46K	–	1813
2021 Q4	$46K	Buy	+2,890	New	+$50.5K	0.02%	1149

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

State of Wyoming's CHRS Position: Q2 2025 in Review

State of Wyoming sold out of Coherus Oncology (CHRS) in Q2 2025, closing a stake of 49,099 shares — an estimated $39.6K sold.

State of Wyoming first reported a position in CHRS in Q4 2021 and held it in 4 quarters. The position peaked at $165K in Q4 2024. 112 funds tracked by Wall St. Rank hold CHRS as of Q2 2025.

State of Wyoming reported no remaining Coherus Oncology position as of Q2 2025 after selling out during the quarter.
State of Wyoming sold 49,099 Coherus Oncology shares in Q2 2025, an estimated $39.6K.
State of Wyoming first reported a position in Coherus Oncology in Q4 2021 and held it in 4 quarters.
State of Wyoming's Coherus Oncology position peaked at $165K in Q4 2024.
112 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2025.

Based on State of Wyoming's 13F filing for Q2 2025, filed 19 Aug 2025.